Pierre Casellas
50Patents
11h-index
48Co-inventors
78Inventor score
Filing activity: Nov 1, 1982 → Jun 16, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5624941A | Pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present | Chemistry; Metallurgy | 214 | Expired |
| US5462960A | Pyrazole-3-carboxamide derivatives, process for their preparation and pharmaceutical compositions in which they are present | Human Necessities | 83 | Expired |
| US5925768A | 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity | Human Necessities | 66 | Expired |
| US6013648A | CB.sub.2 Receptor agonist compounds | Human Necessities | 55 | Expired |
| US6642258B1 | Use of central cannabinoid receptor antagonist for preparing medicines | Human Necessities | 29 | Expired |
| US6767533B1 | Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress | Emerging Cross-Sectional Technologies | 29 | Expired |
| US7504511B2 | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | Chemistry; Metallurgy | 21 | Active |
| US6482986B1 | Benzene derivatives, preparation method and pharmaceutical compositions containing same | Chemistry; Metallurgy | 20 | Expired |
| US7777041B2 | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | Chemistry; Metallurgy | 20 | Active |
| US6126133A | Slide rail for vehicle seat and seat comprising such a slide rail | Performing Operations; Transporting | 18 | Expired |
| US4981953A | Immunotoxins, process for their preparation and pharmaceutical compositions in which they are present | Human Necessities | 14 | Expired |
| US6257541A | Slide for vehicle seat, and seat including such slide | Performing Operations; Transporting | 11 | Expired |
| US6689797B2 | Tetrahydropyridines, preparation method and pharmaceutical compositions containing same | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6967203B2 | Use of pyridoindolone derivatives for preparing anticancer medicines | Human Necessities | 6 | Expired |
| US4749566A | Pharmaceutical composition comprising a combination of at least one immunotoxin and at least one mannose-containing polymer | Emerging Cross-Sectional Technologies | 6 | Expired |
| US4911911A | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5354781A | Benzene derivatives, their preparation and pharmaceutical compositions in which they are present | Chemistry; Metallurgy | 5 | Expired |
| US4643895A | Anti-cancer drugs for the treatment of leukaemias I, constituted by the chain A of ricin and a specific monoclanal antibody | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6344464B1 | Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination | Human Necessities | 5 | Expired |
| US4911912A | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoprotein | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7504406B2 | Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same | Human Necessities | 4 | Active |
| US7598392B2 | 2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof | Chemistry; Metallurgy | 3 | Active |
| US7186720B2 | Tetrahydropyridyl-alkyl-heterocycles, method for preparing the same and pharmaceutical compositions containing the same | Chemistry; Metallurgy | 3 | Expired |
| US5037960A | Inhibitor of protein synthesis, process for its isolation, its use and pharmaceutical compositions in which it is present | Human Necessities | 2 | Expired |
| US6509351B1 | Phenyl- and pyridyl-tetrahydro-pyridines having TNF inhibiting activity | Performing Operations; Transporting | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.